ICD-10 Code C83.1A | Mantle cell lymphoma, in remission Symptoms, Diagnosis, Billing

Mantle cell lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of B-cells in the mantle zone of lymphoid follicles. It is often aggressive but can enter remission with appropriate treatment. The ICD-10 Code C83.1A is essential for accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track treatment outcomes and resource utilization effectively.

What is ICD-10 Code C83.1A for Mantle cell lymphoma, in remission?

ICD-10 Code C83.1A represents Mantle cell lymphoma, in remission, indicating that the disease has responded to treatment and is currently not active. This code is used in clinical documentation and billing to signify the patient's status, allowing for appropriate management and follow-up care while ensuring accurate coding for reimbursement purposes.

ICD-10 Code C83.1A – Clinical Definition and Explanation of Mantle cell lymphoma, in remission

Mantle cell lymphoma is caused by genetic mutations leading to uncontrolled growth of B-lymphocytes. It typically presents with lymphadenopathy, splenomegaly, and may involve the gastrointestinal tract. The condition requires medical attention due to its aggressive nature and potential complications.

Key Clinical Features:

• Lymphadenopathy in cervical, axillary, or inguinal regions.
• Splenomegaly or hepatomegaly may be present.
• Symptoms of B-cell lymphoma such as fever, night sweats, and weight loss.
• Potential gastrointestinal involvement leading to abdominal pain.

ICD-10 Code C83.1A for Mantle cell lymphoma, in remission – SOAP Notes & Clinical Use

ICD-10 Code C83.1A is utilized in SOAP notes to document the patient's remission status, guiding treatment decisions and follow-up care. It plays a crucial role in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code C83.1A for Mantle cell lymphoma, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C83.1A connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of Mantle cell lymphoma in remission. This ensures continuity of care, supports billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code C83.1A – Mantle cell lymphoma, in remission

Management of Mantle cell lymphoma in remission focuses on monitoring and supportive care. While antibiotic therapy is not typically indicated, ongoing treatment strategies are essential.

Antibiotic Therapy:

• Not applicable as Mantle cell lymphoma is not an infectious condition.

Supportive Care:

• Regular follow-up appointments to monitor for recurrence.
• Management of any treatment-related side effects.
• Nutritional support and counseling.

Infection Control:

• Standard precautions to prevent infections in immunocompromised patients.
• Vaccination updates as per guidelines.

How to Document Symptoms of Mantle cell lymphoma, in remission (ICD-10 C83.1A) in SOAP Notes

Subjective:

• Patient reports feeling well with no new symptoms.
• Denies fever, night sweats, or weight loss.
• History of previous lymphadenopathy now resolved.
• Patient expresses concern about potential recurrence.

Objective:

• Physical examination shows no palpable lymphadenopathy.
• Splenomegaly not noted on examination.
• Vital signs stable with no signs of infection.
• Laboratory results indicate normal blood counts.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Mantle cell lymphoma, in remission (ICD-10 Code C83.1A)

Assessment:

• Mantle cell lymphoma, in remission (ICD-10 Code C83.1A).
• No current symptoms or signs of disease activity.
• Patient's previous treatment history includes chemotherapy and/or immunotherapy.
• Regular monitoring for recurrence is essential.

Plan:

• Continue regular follow-up every 3-6 months.
• Educate patient on signs of recurrence and when to seek care.
• Monitor blood counts and imaging as indicated.
• Schedule next follow-up appointment in 3 months.

Treatment & Plan Section for ICD-10 Code C83.1A – Mantle cell lymphoma, in remission

• Regular follow-up appointments to monitor for signs of recurrence.
• Patient education on lifestyle modifications and symptom awareness.
• Routine laboratory tests to assess overall health and detect any abnormalities.
• Psychosocial support to address emotional and psychological needs.

Using ICD-10 Code C83.1A for Mantle cell lymphoma, in remission in Billing & SOAP Note Compliance

• Ensure accurate documentation of patient history and current status in SOAP notes.
• Use C83.1A in conjunction with any relevant treatment codes for billing.
• Document any symptoms or findings that support the diagnosis.
• Align treatment plans with clinical guidelines to justify billing.

Related ICD-10 Codes Often Used with Mantle cell lymphoma, in remission

ICD-10 Code C83.1A in Medical Billing and Insurance for Mantle cell lymphoma, in remission

ICD-10 Code C83.1A is critical for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant patient history and treatment details to support claims.
• Use C83.1A in conjunction with procedure codes for comprehensive billing.
• Ensure that the diagnosis aligns with the services provided for reimbursement.
• Maintain clear and concise documentation to facilitate the claims process.

Common CPT Pairings: